Annaliesa Anderson
0000-0002-6413-1718
3 papers found
Refreshing results…
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Accelerated preclinical paths to support rapid development of COVID-19 therapeutics
Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp)
Missing publications? Search for publications with a matching author name.